Study of Clinical Application of 18 F-FDG SPECT with Coincidence in the Recurrent or Metastatic Tumor of Colorectal Carcinoma
王荣福,杨熊飞,张春丽,张建华,张旭初,付占立,范岩,胡怀湘,王彦福,田红,郭凤琴,徐文怀
DOI: https://doi.org/10.3760/cma.j.issn.2095-2848.2004.04.006
2004-01-01
Abstract:Objective To investigate the clinical value of 18 F-fluorodeoxyglucose (FDG) SPECT with coincidence in the diagnosis of recurrent or metastatic tumor of colorectal carcinoma. Methods Thirty-one cases of postoperative patients with colorectal cancer were enrolled in this study with 18 F-FDG SPECT with coincidence. The results were analyzed by calculating its accuracy,sensitivity,specificity,positive predictive value (PPV),negative predictive value (NPV),95% confidence interval and compared with US,CT and MRI. Results In 31 cases of postoperative patients with colorectal cancer in this study,there were 19 positive cases,and 2 false negative cases. There was no false positive case. The accuracy,sensitivity,specificity,PPV and NPV were 93.5%,90.5%,100%,100%,83.3%,respectively,and their 95% confidence interval were 78%～99%,70%～99%,69%～100%,82%～100%,69%～100%,respectively. The diagnostic accuracy of 18 F-FDG SPECT was higher than that of CT and US,and the sensitivity and NPV were significantly higher than that of US. The analysis of 95% confidence interval showed a higher tendency in 18 F-FDG SPECT than in US,CT and MRI. Conclusion 18 F-FDG SPECT has high clinical value in the diagnosis of recurrent or metastatic tumor of colorectal carcinoma.